No Data
No Data
Tohoku Pharmaceutical: 2024 Semi-Annual Report Summary
Tohoku Pharmaceutical: Semi-Annual Report 2024
Express News | Northeast Pharmaceutical Group: net income of 0.157 billion yuan in the first half of the year, a year-on-year increase of 16.25%.
Express News | Northeast Pharmaceutical Group: Net income in the first half of the year increased by 16.25% compared to the same period last year.
Northeast Pharmaceutical Group (000597.SZ): The net income in the first half of the year was 0.157 billion yuan, an increase of 16.25% year-on-year.
On August 27th, Northeast Pharmaceutical Group (000597.SZ) released its semi-annual report, with revenue of 4.169 billion yuan, a decrease of 7.50% year-on-year, net income of 0.157 billion yuan, an increase of 16.25% year-on-year, non-GAAP net income of 0.1 billion yuan, an increase of 27.58% year-on-year, and basic earnings per share of 0.110 yuan.
A-share vitamins sector continues to decline, Northeast Pharmaceutical Group hits the limit down.
On August 13th, Northeast Pharmaceutical Group briefly hit the limit down, with Hunan Er-Kang Pharmaceutical, Minsheng Health, Zhejiang Shengda Bio-Pharm and Guangdong Zhongsheng Pharmaceutical following the decline.
No Data